<DOC>
	<DOCNO>NCT02179580</DOCNO>
	<brief_summary>Ministry Health Welfare Department Chinese Medicine pharmacy specially subsidize domestic teaching hospital install clinical study center Chinese pharmacy , order establish clinical study environment Chinese pharmacies meet international regulation , assist promote perform clinical study Chinese pharmacy , improve nation 's health benefit . This render Chinese pharmacy competitive international market employ scientific test verification . The new project application respectively follow : A randomized double blind placebo control study Xiang-Sha-Liu-Jun-Zi-Tang ( XSLJZT ) patient irritable bowel syndrome The main clinical manifestation irritable bowel syndrome ( IBS ) chronic , recurrent abdominal pain abdominal dyscomfortable associate change defecation habit , constipation and/or diarrhea . Clinical treatment IBS include behavioral , drug treatment , anti-diarrheal agent , 5-HT3 receptor antagonist 5-HT4 receptor agonist , treatment relieve partial symptom . Xiang-Sha-Liu-Jun-Zi-Tang ( XSLJZT ) origins Yizongjinjion , use XSLJZT treat patient qi deficiency , phlegm-retained fluid , nausea vomiting , gastrointestinal dysharmony produce many symptom . These symptom mentioned-above similar IBS . Therefore , purpose present study investigate therapeutic effect XSLJZT IBS , investigator design randomize double blind placebo control study assess effect XSLJZT IBS .</brief_summary>
	<brief_title>A Study Xiang-Sha-Liu-Jun-Zi-Tang Patients With Irritable Bowel Syndrome</brief_title>
	<detailed_description>Ministry Health Welfare Department Chinese Medicine pharmacy specially subsidize domestic teaching hospital install clinical study center Chinese pharmacy , order establish clinical study environment Chinese pharmacies meet international regulation , assist promote perform clinical study Chinese pharmacy , improve nation 's health benefit . This render Chinese pharmacy competitive international market employ scientific test verification . The new project application respectively follow : A randomized double blind placebo control study Xiang-Sha-Liu-Jun-Zi-Tang ( XSLJZT ) patient irritable bowel syndrome The main clinical manifestation irritable bowel syndrome ( IBS ) chronic , recurrent abdominal pain abdominal dyscomfortable associate change defecation habit , constipation and/or diarrhea . Clinical treatment IBS include behavioral , drug treatment , anti-diarrheal agent , 5-HT3 receptor antagonist 5-HT4 receptor agonist , treatment relieve partial symptom . Xiang-Sha-Liu-Jun-Zi-Tang ( XSLJZT ) origins Yizongjinjion , use XSLJZT treat patient qi deficiency , phlegm-retained fluid , nausea vomiting , gastrointestinal dysharmony produce many symptom . These symptom mentioned-above similar IBS . Therefore , purpose present study investigate therapeutic effect XSLJZT IBS , design randomize double blind placebo control study assess effect XSLJZT IBS . In addition performance clinical study project Chinese pharmacy , center still maintain cooperation domestic foreign biotechnology industry , industry Chinese herbal medicine academic research institute , material research institute Industrial Technology Research Institute , Feng Chia University , Yuanpei University , make effort expand study development novel Chinese medicinal drug novel medical technique , cooperate famous international Contract Research Organizations ( CRO ) . We want build clinical study service platform , internal part integrate various R &amp; D unit campuses hospital , team department medical care , department medical technology , laboratory , incubation center , biostatistics center , administrative department improve internal procedure perform clinical study . The external part make effort win domestic foreign clinical study case perform center . The perform method illustrate follow : 1 . Setting environment related equipment enable performance clinical study Chinese pharmacy establish operation manual standard operation procedure perform R &amp; D stage drug Chinese pharmacy . 2 . Employing professional require clinical study Chinese pharmacy encourage doctor , pharmacist nurse attend advanced study receive train enhance incubation require professional clinical study , experience pass others . 3 . Practically perform one proposal develop new drug Chinese pharmacy clinical study proposal reassess therapeutic efficacy drug drug permission certificate issue Committee Chinese Medicine Pharmacy record . 4 . Promoting building intact strong audit system accordance Good Clinical Practice ( GCP ) , elevate clinical study level country , put regulation GLP practice . 5 . Promoting cooperation industry , academic , government international cooperation .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>1 . Age : 20 y/o 65 y/o . 2 . Gender : male female . 1 . Pregnant lactating . 2 . Elevated serum ALT / AST level ( 3 x upper limit normal ( ULN ) ) , great normal serum Creatinine . 3 . The client psychological cooperate . ( ex . depression , schizophrenia ) 4 . Abdominal surgery . 5 . Major medical disease . ( ex . heart failure , myocardial infarction , chronic obstructive pulmonary disease , kidney failure , cancer , stroke ) 6 . The patient refuse sign inform consent form .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Traditional Chinese Medicine</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>Good Clinical Practice</keyword>
</DOC>